OverviewSuggest Edit

Kangstem Biotech (강스템바이오텍) is a biopharmaceutical company that focuses on blood-derived stem cell therapy. It develops therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem cells. Additionally, the company provides the technology to isolate the non hematological system stem cell with multi conversion and high purity from the cord blood.
TypePublic
Founded2010
HQKR
Websitekangstem.com

Locations

Kangstem Biotech is headquartered in
Korea (Republic of)

Location Map

Latest Updates

Share Price (Oct 2020)₩7.8 K(+11%)
Cybersecurity ratingAMore

Kangstem Biotech Office Locations

Kangstem Biotech has an office in
Show all (1)

Kangstem Biotech Financials and Metrics

Kangstem Biotech Revenue

Market capitalization (8-Oct-2020)

163.4b

Closing stock price (8-Oct-2020)

7.8k
Kangstem Biotech's current market capitalization is ₩163.4 b.
Show all financial metrics

Kangstem Biotech Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Kangstem Biotech Online and Social Media Presence

Embed Graph

Kangstem Biotech Frequently Asked Questions

  • When was Kangstem Biotech founded?

    Kangstem Biotech was founded in 2010.

  • Who are Kangstem Biotech competitors?

    Competitors of Kangstem Biotech include DeNovaMed, Ventus Therapeutics and Abcombi Biosciences.

  • Where are Kangstem Biotech offices?

    Kangstem Biotech has an office in.

  • How many offices does Kangstem Biotech have?

    Kangstem Biotech has 1 office.